XML 25 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Patents and Trademarks, Net
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]
8
.
Patents and trademarks, net
 
Patents
and trademarks consist of the following:
 
   
December 31,
 
   
2017
   
2016
 
                 
Purchased and licensed patent rights
  $
566
    $
566
 
Internally developed patents
   
1,686
     
1,686
 
Trademarks
   
148
     
148
 
Total
   
2,400
     
2,400
 
Accumulated amortization
  $
(1,992
)   $
(1,906
)
Total intangible assets, net
  $
408
    $
494
 
 
Amortization expense was
$86,
$98,
and
$99
for the years ended
December 31, 2017,
2016,
and
2015,
respectively, and is included in research and development expense in the consolidated statements of operations and comprehensive loss. The estimated aggregate amortization expense for each of the
five
succeeding years is as follows:
 
 
 
December 31,
 
Aggregate Amortization Expense
 
2018
  $
86
 
2019
   
84
 
2020
   
81
 
2021
   
56
 
2022
   
29
 
Thereafter
   
72
 
Total   $
408
 
 
Accumulated amortization for the year
s ended
December 31, 2017
and
2016
is as follows:
 
   
December 31,
 
   
2017
   
2016
 
                 
Purchased and licensed patent rights
  $
(541
)   $
(534
)
Internally developed patents
   
(1,326
)    
(1,253
)
Trademarks
   
(125
)    
(119
)
Total
  $
(1,992
)   $
(1,906
)
 
The weighted average amortization periods for the years ended
December 31, 2017
and
2016
are as follows:
 
 
   
December 31,
 
   
2017
   
2016
 
                 
Purchased and licensed patent rights
   
17
     
17
 
Internally developed patents
   
17
     
17
 
Trademarks
   
10
     
10
 
 
Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy
technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and
no
further royalties, license fees or other amounts will be payable in the future under the license agreements.
 
    
In addition to the purchased and licensed patents, the Company has
capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.